This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

NewLink Genetics Corp (NLNK)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 195.62M 190.40M 61.29M 20.25M
Receivables 5.39M 19.33M 1.66M 738.00K
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 2.18M 12.39M 249.00K 2.40M
Total Current Assets 208.14M 230.46M 63.97M 23.39M
Property, Plant & Equipment, Gross 16.92M 12.55M 10.45M 9.02M
Accumulated Depreciation & Depletion 6.52M 4.96M 3.86M 2.98M
Property, Plant & Equipment, Net 10.40M 7.60M 6.59M 6.04M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 0.00 0.00 0.00 0.00
Total Non-Current Assets 10.40M 7.60M 6.59M 6.04M
Liabilities & Shareholder Equity
Total Assets 218.54M 238.06M 70.56M 29.43M
Accounts Payable 3.66M 2.41M 612.00K 972.00K
Short Term Debt 13.00K 35.00K 35.00K 204.00K
Other Current Liabilities 955.00K 84.00K 130.00K 0.00
Total Current Liabilities 14.84M 25.02M 3.88M 2.92M
Long Term Debt 368.00K 941.00K 987.00K 1.14M
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 7.56M 8.32M 7.32M 1.41M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 7.93M 9.26M 8.35M 8.58M
Total Liabilities 22.77M 34.28M 12.23M 11.50M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 195.77M 203.78M 58.33M 17.93M
Common Par 288.00K 280.00K 266.00K 210.00K
Additional Paid In Capital 276.61M 236.84M 194.04M 122.51M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -80.35M -33.12M -135.98M -104.80M
Treasury Stock -771.00K -222.00K 0.00 0.00
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 196.14M 204.72M 59.31M 19.07M
Total Equity 195.77M 203.78M 58.33M 17.93M
Total Liabilities & Stock Equity 218.54M 238.06M 70.56M 29.43M
Total Common Shares Outstanding 28.81M 27.98M 26.57M 20.99M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 24.03K 10.39K 0.00 0.00
Basic Weighted Shares Outstanding 28.59M 27.84M 25.28M 20.78M
Diluted Weighted Shares Outstanding 28.59M 31.03M 25.28M 20.78M
Number of Employees 210 130 104 94
Number of Part-Time Employees 0 0 0 0
NLNK News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

NLNK NewLink Genetics Corp

Chart of NLNK

Analysts Ratings for NLNK

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 4 3
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET NLNK ANALYST REPORT

NLNK Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs